Decker et al. showed that reduction of PDGF signaling in MSCs by deletion of Pdgfra or by treatment with imatinib reduced myelofibrosis in the TPO overexpression model of MPN (9). The gene discussed is PDGFRA; the disease is myelofibrosis.